ArticleChemistry & biodiversity2026
Phytochemical Characterization of Echeveria "Blue Curls" and Its Association With Redox-Metabolic Perturbations in Melanoma Cells.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanoma cells exhibit characteristic vulnerabilities in redox homeostasis and metabolic plasticity, making these processes attractive targets for natural-product-based intervention. In the present study, the aqueous extract of Echeveria "Blue Curls" (BCAE) was investigated through integrated phytochemical profiling, computational analysis, and cellular assays in B16-F10 melanoma cells. Untargeted GC-MS analysis tentatively identified eight putative metabolites, predominantly saccharides and organic acids, while molecular docking generated hypothetical binding models between selected constituents and the catalytic domain of NADPH oxidase 2 (NOX2). BCAE treatment was associated with reduced intracellular reactive oxygen species (ROS) and mitochondrial superoxide, accompanied by changes in NOX2 protein abundance and antioxidant-related protein expression. These responses coincided with mitochondrial depolarization, altered expression of glycolysis-, fatty acid oxidation-, and mitochondrial bioenergetic-related genes, reduced intracellular lipid accumulation, increased expression of apoptosis-associated genes, and impaired migratory capacity. In contrast, no significant reduction in cell viability was observed in NIH/3T3 fibroblasts under the same conditions. Collectively, these findings indicate that BCAE exposure is associated with coordinated alterations in redox status, mitochondrial function, and metabolism-related cellular responses in melanoma cells. Because this study relied primarily on transcriptional profiling, computational prediction, and in vitro analyses, the findings should be regarded as exploratory and hypothesis-generating.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.